Latest Europe News

EOS has reported a 126% increase in its contract backlog to $307 million in 1H 2025, driven by strong demand for its defence and space technologies despite a revenue decline. The company secured a landmark €71.4 million high energy laser weapon export contract and continues to strengthen its balance sheet.

Altamin Limited announces a significant board and executive reshuffle, appointing Peter Edwards as non-executive Chairman and Geraint Harris as incoming CEO, signaling a renewed focus on critical raw materials for Europe’s energy transition.

GQG Partners reported a robust first half of 2025 with funds under management rising to US$172.4 billion and net revenue increasing 11%, driven by solid net inflows and capital appreciation. The firm also expanded its product suite, including launching an active ETF, while maintaining strong investment performance across strategies.

GLG Corp has significantly revised its profit guidance for FY2025, now expecting a net loss of up to $1.5 million, a sharp increase from earlier estimates.

Australian Vintage reported a slight sales dip in FY25 but improved earnings and cash flow, setting the stage for a transformational FY26 driven by innovative brands and strategic expansion.

Orbital Corporation reveals a strategic pivot amid evolving US drone policies, with a new management team driving growth beyond Boeing Insitu. FY25 guidance shows revenue decline but promising new contracts.

Orbital UAV secures $3 million through a share placement to boost manufacturing capabilities and expand business development amid new US drone market opportunities.

Codan Limited reported a robust FY25 with 22% revenue growth to $674.2 million and a 27% jump in net profit, driven by organic expansion and strategic acquisitions. The company’s communications and metal detection segments both posted solid gains, setting a confident tone for FY26.

Medical Developments International has reported a remarkable turnaround in FY25, posting a net profit after tax and securing paediatric approval for its flagship product Penthrox in Europe.

Medical Developments International Ltd reported an 18% increase in revenue to $39.1 million for FY25, returning to profitability with a net profit after tax of $0.1 million. The company advanced its Penthrox market expansion through regulatory approvals and new partnerships.

Sonic Healthcare reported solid FY2025 results with revenue up 7.6% and a steady profit increase, while declaring a 63-cent final dividend. The company’s recent German acquisition and ongoing synergy efforts set the stage for robust earnings growth in FY2026.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.